Pilocarpine Hydrochloride ( DrugBank: Pilocarpine )


1 disease
IDDisease name (Link within this page)Number of trials
53Sjogren syndrome2

53. Sjogren syndrome


Clinical trials : 305 Drugs : 325 - (DrugBank : 104) / Drug target genes : 58 - Drug target pathways : 188
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000001460
2008/10/0129/10/2008The efficacy and safety of pirocarpine hydrochloride for juvenile Sjogren's syndromeThe efficacy and safety of pirocarpine hydrochloride for juvenile Sjogren's syndrome - Efficacy of pirocarpine for juvenile SS Sjogren's syndromeOral pilocarpine hydrochloride for 4 weeks.Department of Pediatrics, Graduate School of Medicine, Chiba UniverityNULLComplete: follow-up complete6years-old16years-oldMale and Female10Not selectedJapan
2NCT04470479
(ClinicalTrials.gov)
March 1, 20057/7/2020Oral Pilocarpine in the Treatment of the Dry Eye of Patients With Sjogrens SyndromeOral Pilocarpine in the Treatment of the Dry Eye of Patients With Sjogrens SyndromeDry EyeDrug: Pilocarpine Hydrochloride;Drug: PlaceboFederal University of São PauloNULLCompleted18 Years65 YearsAll32Phase 3Brazil